| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.006 |